Matthew J. Townsend, MD, MSc

Duke University Medical Center
Boston, MA

Presentation(s):

• 29 - Infliximab Versus Vedolizumab in Outpatient Treatment of Immune Checkpoint Inhibitor Colitis

  Tuesday, October 29, 2024
  8:40 AM - 8:50 AM ET